Showing results (41-50 of 128) with videos related to
Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2020
Randomized trial shows healthcare payment reform has equal-sized spillover effects on patients not targeted by reformLiran Einav, Amy Finkelstein, Yunan Ji, et al.The Journal of Political Economy|April 30, 2021
The Value of Medicaid: Interpreting Results from the Oregon Health Insurance ExperimentAmy Finkelstein, Nathaniel Hendren, Erzo F P LuttmerProceedings of the National Academy of Sciences of the United States of America|October 21, 2020
Initial economic damage from the COVID-19 pandemic in the United States is more widespread across ages and geographies than initial mortality impactsMaria Polyakova, Geoffrey Kocks, Victoria Udalova, et al.Science (New York, N.Y.)|June 30, 2018
Predictive modeling of U.S. health care spending in late lifeLiran Einav, Amy Finkelstein, Sendhil Mullainathan, et al.JAMA Health Forum|October 7, 2022
Financial Incentives to Facilities and Clinicians Treating Patients With End-stage Kidney Disease and Use of Home Dialysis: A Randomized Clinical TrialYunan Ji, Liran Einav, Neale Mahoney, et al.The Review of Economics and Statistics|June 4, 2026
Heterogeneity in Damages from A PandemicAmy Finkelstein, Geoffrey Kocks, Maria Polyakova, et al.The American Economic Review|August 10, 2018
The Economic Consequences of Hospital AdmissionsCarlos Dobkin, Amy Finkelstein, Raymond Kluender, et al.The Quarterly Journal of Economics|June 1, 2026
LIVES VERSUS LIVELIHOODS: THE IMPACT OF THE GREAT RECESSION ON MORTALITY AND WELFAREAmy Finkelstein, Matthew J Notowidigdo, Frank Schilbach, et al.The American Economic Review|February 16, 2018
The Economic Consequences of Hospital AdmissionsCarlos Dobkin, Amy Finkelstein, Raymond Kluender, et al.The Review of Economics and Statistics|January 16, 2016
MORAL HAZARD IN HEALTH INSURANCE: DO DYNAMIC INCENTIVES MATTER?Aviva Aron-Dine, Liran Einav, Amy Finkelstein, et al.Pageof 13